Cargando…

549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program

BACKGROUND: Hereditary angioedema (HAE) is a rare disorder characterized by C1 esterase inhibitor (C1-INH) deficiency. Clinically, HAE is characterized by relapsing episodes of edema at various body sites followed by disease-free intervals of variable duration. Episodes of upper airway obstruction (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Saguer, Inmaculada, Aygören-Pürsün, Emel, Rusicke, Eva, Klingebiel, Thomas, Kreuz, Wolfhart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization Journal 2012
Materias:	Abstracts of the XXII World Allergy Congress
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512583/ http://dx.doi.org/10.1097/01.WOX.0000411664.07634.b7

Ejemplares similares

On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
por: Aygören-Pürsün, Emel, et al.
Publicado: (2010)

Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
por: Andarawewa, S., et al.
Publicado: (2022)

83 Hereditary Angioedema and Normal C1-Inhibitor (HAE TYPE III): A Novel Mutation in the Coagulation Factor 12 Gene
por: Bork, Konrad, et al.
Publicado: (2012)

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history
por: Aygören-Pürsün, E, et al.
Publicado: (2013)

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014)

453 A 26-Year Review of Long-term Safety of a Human Pasteurized C1 Inhibitor Concentrate
por: Bork, Konrad, et al.
Publicado: (2012)

588 Delayed Diagnosis of Hereditary Angioedema. A Case Report
por: González-Díaz, Sandra, et al.
Publicado: (2012)

457 Clinical Features and Outcome of 82 Patients with Hereditary Angioedema
por: D'Ottaviano, Fabricio Loffredo, et al.
Publicado: (2012)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

586 Mucocutaneous Disease as a Presentation of Hereditary Angioedema. Report of 2 Cases
por: Alaniz, Angelica
Publicado: (2012)

85 Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks
por: Reshef, Avner, et al.
Publicado: (2012)

456 Hereditary Angioedema: Report of Ten Mexican Patients at West National Medical Center in Guadalajara City
por: Madrigal, Ileana
Publicado: (2012)

84 Immuno-Safety of Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: An Integrated Analysis
por: Hack, Erik, et al.
Publicado: (2012)

Hereditary angioedema (HAE) in Belgium: results from a national survey
por: Van der Poorten, MM, et al.
Publicado: (2023)

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology
por: Bygum, Anette, et al.
Publicado: (2012)

454 Efficacy of Icatibant Versus Fresh Frozen Plasma for Attacks of Hereditary Angioedema: Analysis of Indivudual Symptoms by Attack Site
por: Lara, Alicia, et al.
Publicado: (2012)

458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

163 The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment in Patients With Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
por: Bork, Konrad, et al.
Publicado: (2012)

86 The Efficacy and Safety of Human Plasma-derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

594 Life-Threatening Angioedema without Urticaria (Ae-U)
por: Corey, Jacquelynne, et al.
Publicado: (2012)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

591 A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos
por: Talreja, Neetu, et al.
Publicado: (2012)

580 Eleven Cases of Angioedema with Eosinophilia Treated in a Single Hospital in Japan
por: Nakachi, Shinichiro, et al.
Publicado: (2012)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies
por: Wahn, V., et al.
Publicado: (2012)

590 A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema
por: Lehloenya, Rannakoe, et al.
Publicado: (2012)

218 Thunderstorm-Related Asthma in Patients Sensitised to Olea Europaea Pollen: Twenty Emergency Department Visits for Asthmatic Symptoms in One Single Day
por: Losappio, Laura, et al.
Publicado: (2012)

HAE international home therapy consensus document
por: Longhurst, Hilary J, et al.
Publicado: (2010)

573 Prevalence of Allergen Sensitization in Children with Atopy Suspicion between Six Months and Five Years of Age
por: Marinovic, Maria Angelica, et al.
Publicado: (2012)

558 Severe Asthma: Report of Five Clinical Cases at West National Medical Center, Imss in Guadalajara City, Mexico
por: Torres-Lozano, Carlos, et al.
Publicado: (2012)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
por: Andarawewa, Shimalee, et al.
Publicado: (2021)

Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe
por: Aygören-Pürsün, Emel, et al.
Publicado: (2014)

595 Urticarial Rash Associated with Chest Pain
por: Boulaich, Mouna, et al.
Publicado: (2012)

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
por: Maurer, M., et al.
Publicado: (2018)

A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
por: Aygören‐Pürsün, Emel, et al.
Publicado: (2019)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

The complex role of kininogens in hereditary angioedema
por: Kaplan, Allen P., et al.
Publicado: (2022)

177 Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents With Hypertriglyceridemia
por: Berreondo, Nancy Mendez
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mtutu1rtjqr0oqdq7cuod1ujmb